1-3 of 3
David Dill, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IDH1 Mutant AML Is Susceptible to Targeting De Novo Lipid Synthesis Independent of 2-Hydroxyglutarate and Has a Distinct Metabolic Profile from IDH2 Mutant AML

Daniel Thomas, MD PhD, Yusuke Nakauchi, MD PhD, Manhong Wu, PhD, Ming Zheng, PhD, Subarna Sinha, PhD, David Dill, PhD, Gary Peltz, MD PhD, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 440.
https://doi.org/10.1182/blood-2018-99-115040
Published: 2018
Journal Articles

Mutation in Wilms' Tumor 1 Induces DNA Hypermethylation of PRC2 Targets, Blocks Myelomonocytic Differentiation, and Defines a Novel Subtype of AML Responsive to EZH2 Inhibition

Daniel Thomas, MD PhD, Subarna Sinha, PhD, Linda Yu, Namyoung Jung, BS, Bo Dai, PhD, Andrew J Gentles, PhD, Andrew P. Feinberg, MD, David Dill, PhD, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2014) 124 (21): 780.
https://doi.org/10.1182/blood.V124.21.780.780
Published: 2014
Journal Articles

Leukemia Cell Differentiation upon Targeted Therapy Revealed By a Systems Biology Approach

Yulin Li, MD PhD, Jun Seita, MD, PhD, Dean W Felsher, MD PhD, David Dill, PhD
Journal: Blood
Blood (2014) 124 (21): 5202.
https://doi.org/10.1182/blood.V124.21.5202.5202
Published: 2014